CONFLICTS OF INTEREST STATEMENT The authors have no conflicts of interest to declare
The only covariates with SMDs above the minimum threshold of 0.2 were inclusion year, diabetes duration, obesity, and previous use of DPP-4is, GLP-1 RAs, insulins, and sulfonylureas
Our approach combines clinical oversight, appetite-regulating medication, personalized nutrition guidance, and ongoing monitoring to help you achieve meaningful, long-term results
Therefore, managing type 2 diabetes extends beyond glycemic control, making cardiovascular safety a crucial consideration when selecting an anti-diabetic agent
Behavioral assessments included the rotarod test and open-field maze test
In most cases, yes, but its absolutely critical to disclose all medications to your provider